Computer Science · Artificial Intelligence
Interleukin-6 as a Diagnostic Salivary Biomarker in Oral Squamous Cell Carcinoma and Oral Potentially Premalignant Disorders: A Cross-sectional Pilot Study
Pranay Pratik Ghosh, Sandhya Biswal, Subrat Kumar Sahu, Bandita Panda, Ranjana Giri
See on the mapAbstract
Introduction: Worldwide, Oral Squamous Cell Carcinoma (OSCC) is the 6th major cancer and 2nd major in India. This high prevalence is linked to carcinogens, particularly smoking tobacco and chewing betel nuts and due to lack of a quick, accurate, and cost-effective screening diagnostic tool. Immunological biomarkers have the potential to identify and offer a prognostic assessment of this condition. Interleukin-6 (IL-6) is a significant salivary marker among the many other inflammatory markers. Aim: To assess the level of IL-6 in OSCC and Oral Premalignant Diseases (OPMD). Materials and Methods: The present cross-sectional pilot study was conducted at Pathology department of Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India for detection of IL-6 level in OSCC and OPMD saliva samples. A total of 30 patients from each group diagnosed with OPMD and OSCC were recruited consecutively over the period of two years (June 2022-May 2024). Demographic features such as age, gender, habit of tobacco chewing and site of lesion on buccal mucosa were recorded. The level of IL-6 was determined from saliva sample in each group and was compared with healthy control by using Enzyme-Linked Immunosorbent Assay. Kruskal Wallis test was applied for comparison between medians of two groups. IBM Statistical Package for Social Sciences (SPSS) version 25 was used for statistical analysis. Results: The clinicodemographic features revealed that tobacco chewing was the most common aetiology in 80% of OSCC diagnosed cases and 90% in OPMD cases. The median and Interquartile Range (IQR) of salivary IL-6 in OSCC was 138.28 pg/mL (IQR 44.21-254.69), OPMD’s 24.81 pg/mL (IQR 13.69-53.38) in comparison to healthy controls, 8.71 pg/mL (IQR 5.10-13.08). Conclusion: The findings of this study demonstrate that salivary IL-6 level is higher in OSCC cases than OPMD cases and both have potential in early diagnosis. Due to wide array of functional characterisation saliva biomarkers, it can be a potential non invasive biomarker to differentiate the OSCC and OPMD cases.